Xellia Pharmaceuticals Details

Xellia Pharmaceuticals is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. Our anti-infective treatments are gen...
Xellia Pharmaceuticals is a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections. Our anti-infective treatments are generics that combat serious bacterial and antibiotic resistant infections as well as certain fungal diseases. We are a world leader in the development, manufacturing and supply of fermented anti-infectives sold as active pharmaceutical ingredients and finished dosage forms to key pharmaceutical industry companies. Headquartered in Copenhagen, Denmark and owned by Novo Holdings A/S, Xellia Pharmaceuticals has more than 1800 employees globally. From state-of-the-art manufacturing sites in the U.S., China, Denmark and Hungary to R&D sites in Norway and Croatia; Xellia Pharmaceuticals excels within innovative product development to deliver high quality products to its customers. Our product portfolio of anti-bacterial and anti-fungal products used for the treatment of severe infections, including infections caused by multi-resistant bacteria and fungi, is the foundation for our growth strategy within the antibiotics sector. Xellia is the leading supplier of important anti-infectives vancomycin and colistimethate sodium (CMS). Our success and strong market position is built on more than 115 years experience in the pharmaceutical industry. Xellia Pharmaceuticals' focus its R&D investments within injectable product technologies as we are committed to researching solutions, which not only improve patients' quality of life, but will also save lives. Based on our long-term expertise, we bring value for our stakeholders and signify a patient-centric mindset through an embedded corporate motivation of integrating science and innovation to save lives.
Website
Employees
HQ
+1 453-264-5500
Location
København
Revenue
$291.4M

Technologies

Customer Relationship Management
Domain Name Services
Email Delivery
Email Providers
Email Providers

Notable Alumni

Allan Jensen
Vice President, CPO, Global Sourcing & Procurement
ALK
Amy Walker
Sr. QAPS Area Specialist
Novo Nordisk
Ana Lulic
Operations Management Coordinator
Pfizer

Employees

Information Technology Infrastructure Specialist
Customer Order Management Specialist
Senior Director Global Supply Chain
Environmental Health Safety Specialist
Director

Prospect on LinkedIn

Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download ExtensionRepresents linkedin prospector
Browse Apollo's Directories

"We love the interface, the experience, and most importantly… the results."

Erik Straub

Chief Marketing Officer, Kickfurther

"Using Apollo, we’ve solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects."

Michael Transon

CEO, Victorious

Ready to try it out?

Get started for free, then add your whole team. You can always talk to sales if you’re interested in advanced plans.